CLINICAL TRIALS AND OBSERVATIONS HIV-1–related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4 T-cell lymphocytes

1Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; 2Medecine Interne et Immunologie Clinique, Hopital Antoine Beclere, Assistance Publique-Hopitaux de Paris, Université Paris Sud, Clamart, France; 3First Department of Internal Medicine, University of Cologne, Cologne, Germany; 4School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom; 5Centro Nacional de Epidemiologia, Instituto de Salud Carlos III, Madrid, Spain; 6HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, Division of Population Health, University College London Medical School, London, United Kingdom; 7Inserm U897, Université Victor Segalen Bordeaux, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; 8International Agency for Research on Cancer, Lyon, France; 9AIDS Unit, Clinic of Venerologic & Dermatologic Diseases, Athens University Medical School, Syngros Hospital, Athens, Greece; 10Hospital Clínic-Institut d’Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain; 11Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark; 12Academic Medical Center, University of Amsterdam, The Netherlands; and 13Institut de Santé Publique, d’Epidémiologie et de Développement, Université Victor Segalen, Bordeaux, France